CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 53 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $178,000 | -76.1% | 84,357 | -67.3% | 0.00% | – |
| Q1 2021 | $745,000 | +19.6% | 257,742 | -11.4% | 0.00% | – |
| Q4 2020 | $623,000 | -65.7% | 290,850 | -0.9% | 0.00% | – |
| Q3 2020 | $1,817,000 | +82.8% | 293,422 | +89.8% | 0.00% | – |
| Q2 2020 | $994,000 | +209.7% | 154,587 | +99.8% | 0.00% | – |
| Q1 2020 | $321,000 | -24.8% | 77,384 | +7.1% | 0.00% | – |
| Q4 2019 | $427,000 | +36.0% | 72,246 | +24.2% | 0.00% | – |
| Q3 2019 | $314,000 | -22.5% | 58,159 | +15.9% | 0.00% | – |
| Q2 2019 | $405,000 | +77.6% | 50,193 | +74.7% | 0.00% | – |
| Q1 2019 | $228,000 | +212.3% | 28,735 | +71.6% | 0.00% | – |
| Q4 2018 | $73,000 | – | 16,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |